Αρχική World News 2020 round-up: Our biggest cancer stories of the year

2020 round-up: Our biggest cancer stories of the year

2020 has seen people across the globe impacted by the ongoing COVID-19 pandemic. Science is no exception – with many researchers focusing on the drive to develop treatments for the virus.

But it doesn’t mean that cancer progress has been forgotten. From new oesophageal cancer screening methods to AI collaborations with Google, here are some of the top stories from the year.

COVID-19 and cancer

Without a doubt, the biggest story of the year continues to be the COVID-19 pandemic. We spent this year providing rolling updates covering the pandemic and its impact on people affected by cancer.

COVID-19 has had far reaching effects on all aspects of healthcare in the UK, from disrupting clinical trials and putting a hold on screening services to leaving millions of people across the country waiting for cancer tests, treatment and care.

Over the year, we’ve heard from people affected by cancer who’ve been impacted by COVID-19….

This year, many Cancer Research UK scientists used their considerable expertise to try to help the efforts against COVID-19. One lab in particular used their work on anti-cancer viruses to help develop a virus that could target the virus that causes COVID-19, SARS-CoV-2.And with the latest global push into developing and rolling out a vaccine, we’ve been covering the science behind the research and what it could mean for people with cancer.

Trialling a sponge on a string for oesophageal cancer

This year, results from an unusual early detection test were released. Cytosponge – a sponge inside a pill that collects cells from the oesophagus as it’s pulled back out – presents an opportunity for doctors to spot an early precursor to oesophageal cancer. Researchers discovered that this technique found 10 times more cases of Barrett’s oesophagus in the people that were offered the Cytosponge compared with what GP’s ordinarily do. The results went down extremely well with our community.

Developed over the last 20 years, Cytosponge is now being introduced in Scotland as a ‘simpler alternative to endoscopy’ in a £500,000 programme. And the National Institute for Health and Care Excellence have developed a briefing to support NHS commissioners and staff who are considering implementing Cytosponge into services in England, Wales and Northern Ireland.

A grand challenge with guts

A Cancer Research UK research team working on one of our Cancer Grand Challenges have been tracing the toxic fingerprint of a bug found in our gut.

Using miniature replicas of the gut and huge genetic databases, the team found that a toxic strain of E.coli could be implicated in the development of bowel cancer.

By getting a better understanding of the early triggers that lead to bowel cancer, it could help doctors to detect it earlier, at a stage when treatment is more likely to be successful. Not only that, understanding how the bacteria inside the microbiome affects cancer could help researchers develop new treatments.

Making a live biobank

Cells taken from cancer patients hold key clues for researchers trying to solve the questions that different cancers pose. Because of this, biobanks containing human material taken from across the body – are vital for research. The issue is that in order to preserve cells, they have to either be dropped in a solution of formaldehyde or frozen at -80 degrees – both of which kill the cells.

A lab in Manchester has bucked that trend, developing a biobank of living tissue – pushing forward research into ovarian cancer.

Training AI to help improve breast cancer screening

Cancer Research UK scientists have created a database of anonymised breast cancer scans, which has been used by  Google Health and scientists at Imperial college London to develop AI software that could correctly identify cancers in the database of over 2.5 million images with a similar degree of accuracy as the experts.

We spoke to experts to find how this early stage algorithm was trained and what these initial findings could mean for the NHS and cancer services in the future.

Learning about the lungs

Our scientists have been trying to glean more about how lung cancer works. Researchers on the TRACERx project have been mapping how non-small cell lung cancer tumours impact the immune system and how it adapts to counter the tumour. In addition to that, we’ve funded one of the world’s largest precision medicine clinical trials over the last 5 years and the results are finally in.

And new data from the US National Cancer Institute (NCI) show the clearest signs yet that one of the most promising concepts in modern cancer medicine – targeted therapy – seems to be having an impact in lung cancer.

These are only a few of the many stories that have come out this year and things move ever onwards. Thanks for all your generous donations throughout 2020 that made this brilliant work possible. Merry Christmas and a Happy New Year from Cancer Research UK. 

Alex

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer

On 13 October 2021, the US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with chemotherapy, with or without bevacizumab, for...

From Scan to Scan: The Challenges of Living with Metastatic Cancer

October 15, 2021, by NCI Staff Bethany Ross has been living with metastatic neuroendocrine cancer since she was diagnosed in 2018. Credit: Used with permission from...

The award-winning researcher behind next generation sequencing

Next generation sequencing (NGS) has given the genomic research community ultra-high throughput, scalability, and speed that could only be dreamed of 20 years ago....

Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t Tell Their Doctors

Cancer and cancer treatment come with many side effects, including nausea, vomiting, and pain. In addition to the physical toll, the impacts to a...

Medicare Open Enrollment Starts Tomorrow!

Medicare open enrollment is upon us for 2022. If you are a Medicare recipient, this is the time of year when you can make...

Cancer in My Community: Providing Supportive Care in Serbia

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with...